PD-1 intrinsic signalling promoted tumour growth in melanoma and hepatocarcinoma through a mammalian target of rapamycin (mTOR)/ribosomal protein S6 Kinase (S6K1) pathway [5, 6]. The gene discussed is PDCD1; the disease is neoplasm.